Device / Technology News

RSS

BioSante receives two new US patents covering 2A/Furin technology for expressing proteins

BioSante Pharmaceuticals, Inc. today announced the receipt of two US new patents directed to its 2A/Furin technology for expressing proteins. The first issued US patent, US Pat. No., 7,709,224, covers methods for manufacturing recombinant antibodies. By incorporating our 2A/Furin technology into antibody-expression in viral vectors it is possible to rapidly generate stable, high producing antibody cell lines.

18 May 2010

Launch Diagnostics to distribute MDI's Detect-Ready MRSA assay in UK, France and Republic of Ireland

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.

18 May 2010

REVEAL risk score calculator provides innovative approach to better understand PAH

Actelion Ltd announced today that findings from the REVEAL Registry have confirmed the clinical utility of the REVEAL risk score calculator, a new tool designed to predict 1-year survival in patients with pulmonary arterial hypertension according to data presented at the American Thoracic Society's Annual International Conference.

18 May 2010

Asolva adds infection surveillance tool package to Medici system

Asolva, a leading provider of healthcare data analytics and reporting systems, has added a package of infection surveillance tools to Medici, its clinical information management system. The package will assist pharmacists, physicians and other infection preventionists in tracking and maximizing their antimicrobial stewardship programs.

18 May 2010

Biotage to acquire extraction, evaporation product lines for Sample Preparation from Caliper Life Sciences

Biotage AB, a global leader in tools and technology for medicinal and analytical chemistry, and Caliper Life Sciences, Inc. today announces a transaction under which Biotage is acquiring extraction and evaporation product lines for Sample Preparation from Caliper.

18 May 2010

New study shows DFA testing for H1N1 influenza unreliable in ICU patients

Direct Immunofluorescence Assay testing for H1N1 influenza is unreliable in ICU patients, according to a new study from Stanford University. Multiple methods exist for diagnosing influenza, but data on the utility and accuracy of these tests for H1N1 are still emerging, given the relatively recent onset of the epidemic.

18 May 2010

Sutter Health Sac-Sierra Region selects MedAssets' CarePricer patient bill estimation solution

The Sacramento Sierra Region of Sutter Health has selected MedAssets' patient bill estimation solution, CarePricer®, to provide its patients with accurate Patient Friendly Estimates™ at the point-of-access. Using the solution, Sutter Health's seven hospitals in the region will better educate its patients on their responsibilities upfront to improve collections.

18 May 2010

PositiveID announces early completion of iGlucose system prototype development

PositiveID Corporation announced today that it has completed development of the initial prototype of its iGlucose system, creating a small cradle that connects to any data-capable glucose meter to automatically communicate a diabetic's blood sugar readings to the iGlucose online database.

18 May 2010

Jefferson Regional Medical Center completes Sunrise Enterprise 5.5 upgrade

Eclipsys Corporation, The Outcomes Company®, today announced that Jefferson Regional Medical Center (JRMC), a 471-bed acute care hospital in Pine Bluff, AR, is the first Eclipsys™ client to activate Sunrise Enterprise™ 5.5, a significant uplift to Eclipsys' leading integrated suite of software solutions.

18 May 2010

Covidien introduces EEA Hemorrhoid & Prolapse Stapler Set with DST Series Technology

Covidien, a leading global provider of healthcare products, today announced that it is entering the hemorrhoidopexy market for the first time with EEATM Hemorrhoid & Prolapse Stapler Set with DST SeriesTM Technology.

18 May 2010

NMES may reduce muscle atrophy in patients with severe COPD: Researchers

Neuromuscular electrical stimulation may reduce muscle atrophy in patients with severe chronic obstructive pulmonary disease, according to Canadian researchers.

18 May 2010

Health Discovery receives MICO Award from MDB Capital at Bright Lights Conference

Health Discovery Corporation announced today it received the prestigious MICO Award presented by MDB Capital Group, San Francisco, Calif., at its invitation-only Bright Lights Conference held May 11-12, 2010. Health Discovery Corporation was chosen from among 1,600 publicly traded, small cap companies.

18 May 2010

Health Canada grants Response Biomedical Class 3 Medical Device license for RAMP RSV Assay

Response Biomedical Corporation today announced that it has been granted a Class 3 (near patient/point-of-care) Medical Device license by Health Canada to market its RAMP® Respiratory Syncytial Virus (RSV) Assay in Canada.

18 May 2010

Apnex HGNS System shows promising results in people suffering from OSA

Apnex Medical announced today that preliminary data from a first-in-man clinical study showed significant improvements in sleep for people suffering from obstructive sleep apnea. The Apnex HGNS™ System, developed by the St. Paul-based company, is a device designed to treat OSA, which is a serious life-threatening illness characterized by fragmented sleep and excessive day-time sleepiness.

18 May 2010

Sonablate HIFU treatment now available in Bermuda for patients with prostate cancer

US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies, is pleased to announce that its HIFU treatment for prostate cancer is now available in Bermuda. King Edward VII Memorial Hospital in Bermuda joins more than 100 centers in 30-plus countries to offer the innovative treatment with the Sonablate 500 medical device.

18 May 2010

Cynosure's proprietary aesthetic laser systems receive regulatory approvals in Asia and South America

Cynosure, Inc., today announced four international regulatory approvals that extend the reach of the company's proprietary aesthetic laser systems in Asia and South America.

18 May 2010

Ambry Genetics launches AmbryScreen test for genetic screening of severe, common childhood diseases

Ambry Genetics announced today at the American College of Obstetricians and Gynecologists annual clinical meeting the launch of AmbryScreen™, a genetic screening test used to identify carriers of some of the most severe and common childhood diseases affecting pan-ethnic populations.

18 May 2010

Cardiocom releases new pulse oximeter

Cardiocom today announced the release of its new pulse oximeter. Cardiocom's internally developed pulse oximeter offers better integration with its telehealth platform. Cardiocom designs and manufactures telehealth communication devices and vital sign peripherals including: blood pressure system, weight scale, and now offers its new pulse oximeter.

17 May 2010

BaroFold licenses PreEMT Technology to Nuron Biotech for development of BaroFeron

BaroFold, Inc. today announced that it has entered into an agreement to exclusively license its PreEMT™ Technology to Nuron Biotech for the development of BaroFeron™ and follow-on interferon beta products. BaroFeron is a proprietary recombinant human interferon beta being developed for the treatment of multiple sclerosis. Specific terms of the agreement are not disclosed.

17 May 2010

Health Robotics re-acquires European rights for CytoCare from B. Braun

Health Robotics and B. Braun Melsungen AG today announced that in exchange for undisclosed consideration, Health Robotics has re-acquired from B. Braun the exclusive marketing, sales, installation, implementation, interface, manufacturing, and technical support European rights for CytoCare, a robot designed to manufacture chemotherapy and hazardous IV Admixtures, and which rights B. Braun had previously acquired from Health Robotics in 2007 and 2008.

From B. Braun Melsungen AG 17 May 2010

Device / Technology News

BioSante receives two new US patents covering 2A/Furin technology for expressing proteins

Launch Diagnostics to distribute MDI's Detect-Ready MRSA assay in UK, France and Republic of Ireland

REVEAL risk score calculator provides innovative approach to better understand PAH

Asolva adds infection surveillance tool package to Medici system

Biotage to acquire extraction, evaporation product lines for Sample Preparation from Caliper Life Sciences

New study shows DFA testing for H1N1 influenza unreliable in ICU patients

Sutter Health Sac-Sierra Region selects MedAssets' CarePricer patient bill estimation solution

PositiveID announces early completion of iGlucose system prototype development

Jefferson Regional Medical Center completes Sunrise Enterprise 5.5 upgrade

Covidien introduces EEA Hemorrhoid & Prolapse Stapler Set with DST Series Technology

NMES may reduce muscle atrophy in patients with severe COPD: Researchers

Health Discovery receives MICO Award from MDB Capital at Bright Lights Conference

Health Canada grants Response Biomedical Class 3 Medical Device license for RAMP RSV Assay

Apnex HGNS System shows promising results in people suffering from OSA

Sonablate HIFU treatment now available in Bermuda for patients with prostate cancer

Cynosure's proprietary aesthetic laser systems receive regulatory approvals in Asia and South America

Ambry Genetics launches AmbryScreen test for genetic screening of severe, common childhood diseases

Cardiocom releases new pulse oximeter

BaroFold licenses PreEMT Technology to Nuron Biotech for development of BaroFeron

Health Robotics re-acquires European rights for CytoCare from B. Braun

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News